Research has demonstrated that the p53 protein mutant promotes the survival of cancer cells through increased intracellular reactive oxygen species (ROS) production, proinflammatory cytokine secretion, mTOR signaling activation, decreased autophagic activity, and increased expression of uncoupling protein 2 (UCP2) [188]. The gene discussed is MTOR; the disease is cancer.